Did you know? The total GLP-1 market is projected to reach a potential $200 billion by 2031.
As such, oral solid dose (OSD) formulations are poised to gain significant traction.
This shift demands manufacturing partners with proven expertise in:

💊Specialized potent compound handling

⏳ Modified release technology

🎯 Precise quality control systems

📈 Continuity of supply

https://www.lannettcdmo.co...